Get started
Author

Antoine Capes

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients
2020 · Antoine Guilmot, Sofia Maldonado Slootjes, et al. · Journal of Neurology · 190
PDF
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients
2022 · Mathilde Sourisseau, Emmanuel Faure, et al. · Blood Advances · 18
PDF
Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation
2024 · Tamim Alsuliman, Lugien Alasadi, et al. · The Lancet Haematology · 9
Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation
2022 · Aurélien Sutra Del Galy, Adrien Rousseau, et al. · Bone Marrow Transplantation · 9
Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact
2024 · Annalisa Paviglianiti, Tânia Maia, et al. · Clinical Hematology International · 6
PDF
Impact of the addition of antithymocyte globulin to post‐transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post‐transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation
2025 · Antoine Capes, Jarl E. Mooyaart, et al. · British Journal of Haematology · 5
PDF
Severe cytopenia after chimeric antigen receptor‐T cell driven by large granular lymphocytes and responsive to steroids
2024 · Antoine Capes, Alexandra Morin, et al. · British Journal of Haematology · 5
PDF
Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation
2024 · Lama Siblany, Nicolas Stocker, et al. · Journal of Clinical Immunology · 5
Writing the story of immune effector cell‐associated neurotoxicity syndrome
2024 · Vincent Bonny, Tomas Urbina, et al. · eJHaem · 2
PDF
446 | Impact of Response to Holding/bridging Therapy in Second‐line Dlbcl Patients Treated With Axicabtagene Ciloleucel: a Lysa Study From the French Descar‐t Registry
2025 · A. Capes, A. Cuozzo, et al. · Hematological Oncology · 1
PDF
Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy
2026 · Jean-Roch Le Henaff, Loïc Le Guennec, et al. · Blood Advances
Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group
2026 · Pierre Sesques, Guillaume Manson, et al. · HemaSphere
Outcome of patients with large B-cell lymphoma relapsing after second-line CAR-t: Insights from the descar-t registry
2025 · Pierre Sesques, Guillaume Manson, et al. · Blood
T‐cell‐based immunotherapies for human immunodeficiency virus patient with relapsed/refractory multiple myeloma: A success story from our clinic
2025 · S. Moraru, F. Malard, et al. · British Journal of Haematology
PDF
sMAdCAM‐1 is decreased after allo‐HCT, along with gut microbiota dysbiosis, and is associated with hematopoietic recovery
2025 · Karen Fadel, Lama Siblany, et al. · HemaSphere
PDF
Drug induced neutropenia with myelodysplasia with blast excess.
2018 · Antoine Capes
Des étudiants en médecine s’interrogent sur le diagnostic préimplantatoire (DPI). Compte-rendu d’une démarche réflexive dans le cadre d’un cursus d’éthique
2009 · A. Capes, M.-L. Coilhac, et al. · Éthique & Santé
Works count: 17
Citation count: 250
H-index: 5
I10-index: 2
Year
Topic
Type